1. Male reproductive tract antimicrobial expression in the extremes of ages of rats
    Kumari Sangeeta et al, 2019, Gene CrossRef
  2. Albumin‐Mediated Delivery of Bioactive Peptides for Pancreatic Cancer Therapy
    Yue Du et al, 2020, Advanced Therapeutics CrossRef
  3. Mammalian antimicrobial peptides: defensins and cathelicidins
    Xiangling Cui et al, 2024, Molecular Medical Microbiology CrossRef
  4. Development of a Cell-Based High-Throughput Screening Assay to Identify Porcine Host Defense Peptide-Inducing Compounds
    Zhuo Deng et al, 2018, Journal of Immunology Research CrossRef
  5. Epigenetic Regulation of Host Defense Peptide Synthesis: Synergy Between Histone Deacetylase Inhibitors and DNA/Histone Methyltransferase Inhibitors
    Melanie A. Whitmore et al, 2022, Frontiers in Immunology CrossRef
  6. Application Value of Antimicrobial Peptides in Gastrointestinal Tumors
    Qi Liu et al, 2023, International Journal of Molecular Sciences CrossRef
  7. Roles of Antimicrobial Peptides in Gynecological Cancers
    Chongyi Zhao et al, 2022, International Journal of Molecular Sciences CrossRef
  8. Oral Cavity Beta-Defensin Levels Are Regulated Differently during Radiotherapy in Head and Neck Cancer Patients
    Mutlu Keskin et al, 2023, Applied Sciences CrossRef
  9. Beta-defensin index: A functional biomarker for oral cancer detection
    Santosh K. Ghosh et al, 2024, Cell Reports Medicine CrossRef
  10. Human Beta Defensins and Cancer: Contradictions and Common Ground
    Santosh K. Ghosh et al, 2019, Frontiers in Oncology CrossRef
  11. Occurrence of Human Defensins and S100 Proteins in Head and Neck Basal Cell Carcinoma (BCC) Entities: hBD3 and S100A4 as Potential Biomarkers to Evaluate Successful Surgical Therapy
    Eva Dröge et al, 2023, Journal of Otorhinolaryngology, Hearing and Balance Medicine CrossRef
  12. Nutritional Modulation of Host Defense Peptide Synthesis: A Novel Host-directed Antimicrobial Therapeutic Strategy?
    Melanie Whitmore et al, 2024, Advances in Nutrition CrossRef
  13. Human β-Defensin 2 (HBD-2) Displays Oncolytic Activity but Does Not Affect Tumour Cell Migration
    Guneet K. Bindra et al, 2022, Biomolecules CrossRef
  14. Human β-defensins and their synthetic analogs: Natural defenders and prospective new drugs of oral health
    Mumian Chen et al, 2024, Life Sciences CrossRef
  15. Enediyne-activated, EGFR-targeted human β-defensin 1 has therapeutic efficacy against non-small cell lung carcinoma
    Wen-juan Liu et al, 2018, Laboratory Investigation CrossRef
  16. Defensins: A Double-Edged Sword in Host Immunity
    Dan Xu et al, 2020, Frontiers in Immunology CrossRef
  17. Cell culture models of oral mucosal barriers: A review with a focus on applications, culture conditions and barrier properties
    Lisa Bierbaumer et al, 2018, Tissue Barriers CrossRef
  18. Alterations in gene expression and DNA methylation profiles in gastric cancer cells obtained from ascitic fluids collected before and after chemotherapy
    Osamu Maeda et al, 2019, Molecular and Clinical Oncology CrossRef
  19. The multifaceted roles of antimicrobial peptides in oral diseases
    John Yun Niu et al, 2021, Molecular Oral Microbiology CrossRef
  20. The recombinant defensin/HSA fusion protein that inhibits NF-κb associated with intensive macropinocytosis shows potent efficacy against pancreatic cancer
    Yi-bo Du et al, 2022, Biochemical Pharmacology CrossRef
  21. A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer
    Yue Du et al, 2016, Oncotarget CrossRef
  22. Identification of human host factors required for beta-defensin-2 expression in intestinal epithelial cells upon a bacterial challenge
    Weronika Wozniak et al, 2024, Scientific Reports CrossRef
  23. Human β-defensins: The multi-functional natural peptide
    Haile Zhao et al, 2024, Biochemical Pharmacology CrossRef